Document Detail


Management of severe pulmonary arterial hypertension.
MedLine Citation:
PMID:  21119186     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pulmonary arterial hypertension (PAH) is a severe, progressive condition of the small pulmonary vessels that leads to increased pulmonary vascular resistance, right ventricular failure and death. Patients in World Health Organization functional class (WHO FC) IV are the most severely affected in terms of disease severity, symptomatic impairment, exercise capacity and haemodynamics, with a very poor prognosis and low survival rate. Recent developments in PAH-specific therapies have conferred significant prognostic improvements upon PAH patients, especially when coupled with management strategies such as goal-oriented therapy and combination treatment. Despite these important developments, the outlook for WHO FC IV PAH patients remains poor. This article examines the recommendations for WHO FC IV patients that appear in current PAH treatment guidelines and the research underpinning this guidance, and discusses possible future directions for treatment of this severely unwell patient population.
Authors:
J-L Vachiéry; G Simonneau
Related Documents :
8480646 - Retrobronchial vertical vein in totally anomalous pulmonary venous connection to the in...
21306786 - Advanced management of acute iliofemoral deep venous thrombosis: emergency department a...
19195506 - Usefulness of diastolic dominant pulmonary vein flow to predict hospitalization for hea...
2324136 - Structures at risk from medially placed acetabular screws.
10228546 - Subclavian and internal jugular veins at doppler us: abnormal cardiac pulsatility and r...
10356436 - Intraoperative spasm of coronary and peripheral artery--a case occurring after tourniqu...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  European respiratory review : an official journal of the European Respiratory Society     Volume:  19     ISSN:  1600-0617     ISO Abbreviation:  Eur Respir Rev     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-12-01     Completed Date:  2011-03-17     Revised Date:  2012-01-10    
Medline Journal Info:
Nlm Unique ID:  9111391     Medline TA:  Eur Respir Rev     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  279-87     Citation Subset:  IM    
Affiliation:
Dept of Cardiology, CUB-Hôpital Erasme, Brussels, Belgium. jean-luc.vachiery@ulb.ac.be
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Drug Therapy, Combination
Humans
Hypertension, Pulmonary / classification,  diagnosis*,  therapy*
Lung Transplantation
Practice Guidelines as Topic
Prognosis
Severity of Illness Index*
World Health Organization
Comments/Corrections
Comment In:
Eur Respir Rev. 2010 Dec;19(118):264-5   [PMID:  21119183 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Treat-to-target strategies in pulmonary arterial hypertension: the importance of using multiple goal...
Next Document:  The role of echocardiography in the diagnosis and management of patients with pulmonary hypertension...